Overview

Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

To provide zalcitabine ( ddC ) for patients with AIDS or Advanced ARC in whom zidovudine ( AZT ) is contraindicated, or who have failed treatment with or are intolerant to AZT and to demonstrate that ddC monotherapy is safe, and tolerable in this patient population.

Phase:

N/A

Details

Lead Sponsor:

Hoffmann-La Roche

Treatments:

Zalcitabine
Zidovudine